News & Articles

Multiplex PCR test supports rapid detection of multidrug‑resistant organisms in hospital settings

Offering early access to the new diagnostic paradigm, pilot partnerships with selected institutions engaged by year-end

Seegene is to export COVID-19 tests along with its Master Assay that distinguishes between COVID-19 and other respiratory viruses

The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron, and its stealth version

Seegene will support countries in need of diagnostics to help slow Omicron's spread

A true walk away ‘sample to answer’ molecular diagnostic system designed for high throughput testing, offering a time-efficient and seamless workflow for clinical laboratories

The new MDx system will efficiently access a wide array of Seegene's syndromic assays

Offering user-friendly, efficient specimen collection, the Combo Swab is expected to dramatically improve COVID-19 testing efficiency

The multiplex PCR test is capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases

A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.

The Allplex SARS-CoV-2 Master Assay can detect a total of 10 targets including four coronavirus genes

Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min

Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month

The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world